Journey Medical (DERM) Other financing activities (2021 - 2026)
Journey Medical's (DERM) quarterly Other financing activities came in at $148000.0 in Q1 2026, up 49.49% YoY from $99000.0 in Q1 2025, and up 217.46% on a QoQ basis from -$126000.0 in Q4 2025.
Journey Medical (DERM) Other financing activities (2021 - 2026) Analysis & Trends
Journey Medical (DERM) has 6 years of Other financing activities data on file, last reported at $148000.0 in Q1 2026.
- Quarterly Other financing activities rose 49.49% year-over-year to $148000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $266000.0 (up 11.76% YoY) and the FY2025 annual result came in at $217000.0, up 4.83% from the prior year.
- Other financing activities climbed to $148000.0 in Q1 2026, from -$126000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $31.3 million in Q3 2022 to a low of -$126000.0 in Q4 2025.
- A 5-year average of $4.7 million and a median of $97500.0 in 2023 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 216.88% in 2025, down 380.0% in 2025.
- Tracing DERM's Other financing activities over 5 years: stood at $31.3 million in 2022, then slumped by 99.69% to $96000.0 in 2023, then tumbled by 53.12% to $45000.0 in 2024, then plunged by 380.0% to -$126000.0 in 2025, then soared by 217.46% to $148000.0 in 2026.
- The last three Other financing activities figures came in at $148000.0 (Q1 2026), -$126000.0 (Q4 2025), and $244000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Journey Medical | 211.01 Mn | 185.37 Mn | 12.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 82,000.00 |
| Jun 30, 2026 | 82,000.00 |
| Mar 31, 2026 | 148,000.00 |
| Mar 31, 2026 | 148,000.00 |
| Dec 31, 2025 | -126,000.00 |
| Dec 31, 2025 | -126,000.00 |
| Sep 30, 2025 | 244,000.00 |
| Sep 30, 2025 | 244,000.00 |
| Mar 31, 2025 | 99,000.00 |
| Mar 31, 2025 | 99,000.00 |
| Dec 31, 2024 | 45,000.00 |
| Dec 31, 2024 | 45,000.00 |
| Sep 30, 2024 | 77,000.00 |
| Sep 30, 2024 | 77,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Dec 31, 2023 | 96,000.00 |
| Dec 31, 2023 | 96,000.00 |